Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 7;10(7):1165-1172.
doi: 10.1039/c9md00163h. eCollection 2019 Jul 1.

Synthesis of an α-phosphono-α,α-difluoroacetamide analogue of the diphosphoinositol pentakisphosphate 5-InsP7

Affiliations

Synthesis of an α-phosphono-α,α-difluoroacetamide analogue of the diphosphoinositol pentakisphosphate 5-InsP7

Andrew M Riley et al. Medchemcomm. .

Abstract

Diphosphoinositol phosphates (PP-InsPs) are an evolutionarily ancient group of signalling molecules that are essential to cellular and organismal homeostasis. As the detailed mechanisms of PP-InsP signalling begin to emerge, synthetic analogues of PP-InsPs containing stabilised mimics of the labile diphosphate group can provide valuable investigational tools. We synthesised 5-PCF2Am-InsP5 (1), a novel fluorinated phosphonate analogue of 5-PP-InsP5, and obtained an X-ray crystal structure of 1 in complex with diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2). 5-PCF2Am-InsP5 binds to the kinase domain of PPIP5K2 in a similar orientation to that of the natural substrate 5-PP-InsP5 and the PCF2Am structure can mimic many aspects of the diphosphate group in 5-PP-InsP5. We propose that 1, the structural and electronic properties of which are in some ways complementary to those of existing phosphonoacetate and methylenebisphosphonate analogues of 5-PP-InsP5, may be a useful addition to the expanding array of chemical tools for the investigation of signalling by PP-InsPs. The PCF2Am group may also deserve attention for wider application as a diphosphate mimic.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. A. Inositol hexakisphosphate (InsP6) is phosphorylated on P-5 by IP6K to give 5-PP-InsP5, also known as “5-InsP7”. Further phosphorylation at P-1 by PPIP5K gives 1,5-[PP]2-InsP4, (“InsP8”). B. Stabilised analogues of 5-PP-InsPP5 containing methylenebisphosphonate (PCP), phosphonoacetate (PA) and phosphonodifluoroacetamide (PCF2Am) mimics of the natural PP group. IP6K, inositol hexakisphosphate kinase; PPIP5K, diphosphoinositol pentakisphosphate kinase.
Scheme 1
Scheme 1. Synthesis of 5-deoxy-5-amino-inositol 7. Reagents and conditions: a. see ref. 22; b. i. Tf2O, CH2Cl2, pyridine, –78 °C to r.t.; ii. NaN3, DMF, r.t., 86%; c. i. LiOH·H2O, MeOH, THF, H2O; ii. NaH, BnBr, DMF, 93%; d. i. CH2Cl2, 95% aqueous TFA; ii. NaH, BnBr, DMF, 91%; e. LiAlH4, THF, 100%. Bn, benzyl.
Scheme 2
Scheme 2. a. (EtO)2P(O)CF2COOH, EDAC, CH2Cl2, 87%; b. H2, 50 p.s.i., Pd(OH)2/C, MeOH, THF, AcOH, 100%; c. i. (BnO)2PNiPr2, 5-phenyl-1H-tetrazole, CH2Cl2; ii. mCPBA, 66%; d. i. TMSBr, CH2Cl2; ii. MeOH; iii. aqueous triethylammonium bicarbonate, 85%. Bn, benzyl.
Fig. 2
Fig. 2. A. Inhibition of human PPIP5K2 by 5-PCF2Am-InsP5 (1) in the presence of 100 nM 1,5-[PP]2-InsP4. B. Crystallographic analysis of PPIP5K2 in complex with 1 and AMPPNP (PDB code ; 6N5C). C. The 2Fo–Fc electron density map of 1, contoured at 1.7σ, is shown as light blue mesh. PPIP5K2 is shown in cartoon and 1 is shown as a stick model, with carbon atoms coloured dark grey, phosphorus atoms orange, oxygen atoms red, nitrogen atom blue and fluorine atoms cyan. D. Another view of 5-PCF2Am-InsP5 (1) and its overlap with 5-PP-InsP5, which is shown as white sticks. Panels E and F show the moieties on position 5 of 1 and the natural substrate 5-PP-InsP5 (PDB code, ; 3T9D).

References

    1. Shears S. B. J. Cell. Physiol. 2018;233:1897–1912. - PMC - PubMed
    1. Thomas M. P., Potter B. V. L. FEBS J. 2014;281:14–33. - PMC - PubMed
    1. Riley A. M., Wang H., Weaver J. D., Shears S. B., Potter B. V. L. Chem. Commun. 2012;48:11292–11294. - PMC - PubMed
    1. Riley A. M., Wang H., Shears S. B., Potter B. V. L. Chem. Commun. 2015;51:12605–12608. - PMC - PubMed
    1. Wu M., Dul B. E., Trevisan A. J., Fiedler D. Chem. Sci. 2013;4:405–410. - PMC - PubMed